Benefits, Barriers, and Challenges to Using Proton Therapy for Cancer Treatment
This video reviews the benefits of proton therapy and some of the barriers and challenges preventing the integration of the technology into regular practice.
In this video, Zhongxing Liao, MD, of MD Anderson Cancer Center in Houston, Texas, discusses the benefits of proton therapy and talks about some of the barriers and challenges-such as treatment planning, costs, and insurance reimbursement-preventing the integration of the technology into regular practice.
Liao gave a presentation on this topic earlier this year at the 2017 Multidisciplinary Thoracic Cancers Symposium.
FDA Approves Encorafenib/Cetuximab Plus mFOLFOX6 for Advanced BRAF V600E+ CRC
December 20th 2024The FDA has granted accelerated approval to encorafenib in combination with cetuximab and mFOLFOX6 for patients with metastatic colorectal cancer with a BRAF V600E mutation, as detected by an FDA-approved test.
